Impact of the type of first-cancer therapy in therapy-related myelodysplastic syndromes outcomes.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e18555
Abstract: e18555Background: Therapy-related myelodysplastic syndromes (t-MDS) are known to have poor outcomes. The impact of the therapy received for the first cancer remains unknown. Methods: 228 t-MDS diag... read more here.
Keywords: therapy related; myelodysplastic syndromes; first cancer; therapy ... See more keywords